165 related articles for article (PubMed ID: 2260096)
1. Toxicological studies on a benzofurane derivative. II. Demonstration of peroxisome proliferation in rat liver.
Butler EG; Ichida T; Maruyama H; Schulte-Hermann R; Williams GM
Toxicol Appl Pharmacol; 1990 Dec; 106(3):500-8. PubMed ID: 2260096
[TBL] [Abstract][Full Text] [Related]
2. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
Flatmark T; Christiansen EN; Kryvi H
Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
[TBL] [Abstract][Full Text] [Related]
3. Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture.
Bichet N; Cahard D; Fabre G; Remandet B; Gouy D; Cano JP
Toxicol Appl Pharmacol; 1990 Dec; 106(3):509-17. PubMed ID: 2260097
[TBL] [Abstract][Full Text] [Related]
4. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
Moody DE; Reddy JK
Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
[TBL] [Abstract][Full Text] [Related]
5. Effect of clofibrate application on morphology and enzyme content of liver peroxisomes.
Goldenberg H; Hüttinger M; Kampfer P; Kramar R; Pavelka M
Histochemistry; 1976 Feb; 46(3):189-96. PubMed ID: 1248951
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferation of hepatocytes in rats by a microbial degradation product of cholic acid, 4-(decahydro-6-methyl-3-oxocyclopenta(f)quinoline-7-yl)valeric acid.
Hayashi Y; Toyoda K; Imazawa T; Sato H; Okamiya H; Kurokawa Y; Takahashi J; Mogami-Nishimaki T; Hayakawa S
Exp Toxicol Pathol; 1994 Jul; 46(2):127-32. PubMed ID: 7987070
[TBL] [Abstract][Full Text] [Related]
7. Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators.
Reddy JK; Jirtle RL; Watanabe TK; Reddy NK; Michalopoulos G; Qureshi SA
Cancer Res; 1984 Jun; 44(6):2582-9. PubMed ID: 6372995
[TBL] [Abstract][Full Text] [Related]
8. Studies on peroxisomes. V. Effect of ethyl p-chlorophenoxyisobutyrate on the centrifugal behavior of rat liver peroxisomes.
Hayashi H; Suga T; Ninobe S
J Biochem; 1975 Jun; 77(6):1199-204. PubMed ID: 5399
[TBL] [Abstract][Full Text] [Related]
9. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
[TBL] [Abstract][Full Text] [Related]
10. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate.
Klucis E; Crane DI; Hughes JL; Poulos A; Masters CJ
Biochim Biophys Acta; 1991 Jul; 1074(2):294-301. PubMed ID: 1676600
[TBL] [Abstract][Full Text] [Related]
11. The involvement of selenium in peroxisome proliferation caused by dietary administration of clofibrate to rats.
Olsson U; Garberg P; Lundgren B; Andersson K; Hultenby K; Bergstrand A; Eriksson AM; Högberg J; DePierre JW
Chem Biol Interact; 1992 Nov; 85(1):49-67. PubMed ID: 1458550
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships.
Esbenshade TA; Kamanna VS; Newman HA; Tortorella V; Witiak DT; Feller DR
Biochem Pharmacol; 1990 Sep; 40(6):1263-74. PubMed ID: 2403380
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferators differentially regulate long-chain acyl-CoA thioesterases in rat liver.
Svensson LT; Wilcke M; Alexson SE
Eur J Biochem; 1995 Jun; 230(2):813-20. PubMed ID: 7607256
[TBL] [Abstract][Full Text] [Related]
14. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
[TBL] [Abstract][Full Text] [Related]
15. The effect of clofibrate on amphibian hepatic peroxisomes.
Ciolek E; Dauça M
Biol Cell; 1991; 71(3):313-20. PubMed ID: 1681969
[TBL] [Abstract][Full Text] [Related]
16. Effects of hepatic peroxisome proliferators and 12-O-tetradecanoyl phorbol-13-acetate on catalase and other enzyme activities of embryonic cells in vitro.
Mikalsen SO; Ruyter B; Sanner T
Biochem Pharmacol; 1990 Feb; 39(3):527-35. PubMed ID: 2306265
[TBL] [Abstract][Full Text] [Related]
17. Role of testosterone in the induction of hepatic peroxisome proliferation by clofibrate.
Paul HS; Sekas G; Winters SJ
Metabolism; 1994 Feb; 43(2):168-73. PubMed ID: 8121297
[TBL] [Abstract][Full Text] [Related]
18. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
Leighton F; Coloma L; Koenig C
J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406
[TBL] [Abstract][Full Text] [Related]
19. Change of the sex-dependent response to clofibrate in F344 rat liver during postnatal development.
Yamoto T; Ohashi Y; Furukawa T; Teranishi M; Manabe S; Makita T
Toxicol Lett; 1996 May; 85(2):77-83. PubMed ID: 8650696
[TBL] [Abstract][Full Text] [Related]
20. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
Reddy JK; Krishnakantha TP
Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
